학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 25건 | 목록 1~10
Electronic Resource
Rensen , N , Steur , LMH , Grootenhuis , MA , Eijkelenburg , NKA , Sluis , I , Dors , N , van den Bos , C , Tissing , WJ , Kaspers , GJ & van Litsenburg , RRL 2020 , ' Parental functioning during maintenance treatment for childhood acute lymphoblastic leukemia: Effects of treatment intensity and dexamethasone pulses ' , Pediatric Blood and Cancer , vol. 67 , no. 11 , e28697 .
Electronic Resource
Steur , LMH , Grootenhuis , MA , Someren , EJW , Eijkelenburg , NKA , Sluis , I , Dors , N , van den Bos , C , Tissing , WJ , Kaspers , GJ & van Litsenburg , RRL 2020 , ' High prevalence of parent-reported sleep problems in pediatric patients with acute lymphoblastic leukemia after induction therapy ' , Pediatric Blood and Cancer , vol. 67 .
Electronic Resource
Steur , LMH , Kaspers , GJ , Someren , EJW , Eijkelenburg , NKA , Sluis , I , Dors , N , van den Bos , C , Tissing , WJ , Grootenhuis , MA & van Litsenburg , RRL 2020 , ' The impact of maintenance therapy on sleep-wake rhythms and cancer-related fatigue in pediatric acute lymphoblastic leukemia ' , Supportive Care in Cancer , vol. 28 , no. 12 , pp. 5983-5993 .
Electronic Resource
Tas , ML , Reedijk , AMJ , Kos , H , Kremer , LC , van de Ven , CP , Dierselhuis , MP , Eijkelenburg , NKA , Grotel , M , Kraal , K , Peek , AML , Coebergh , J W , Janssens , GO , Keizer , B , de Krijger , RR , Pieters , R , Tytgat , GA & Noesel , MM 2020 , ' Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma ' , European Journal of Cancer , vol. 124 , pp. 47-55 .
Electronic Resource
Kloos , R , Pieters , R , van den Bos , C , Eijkelenburg , NKA , de Jonge , R & Sluis , I 2019 , ' The effect of asparaginase therapy on methotrexate toxicity and efficacy in children with acute lymphoblastic leukemia ' , Leukemia & Lymphoma , vol. 60 , no. 12 , pp. 3002-3010 .
Academic Journal
Rubio-San-Simón A; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. arubiosansimon@gmail.com.; Department of Pediatric Oncology/Hematology, Niño Jesús Children's Hospital, Madrid, Spain. arubiosansimon@gmail.com.; van Eijkelenburg NKA; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; Hoogendijk R; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; Hasle H; Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.; Niemeyer CM; Department of Pediatric Hematology and Oncology, Center for Pediatrics, Medical Center, University of Freiburg, Freiburg, Germany.; Dworzak MN; St. Anna Children's Cancer Research Institute, Vienna, Austria.; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; Zecca M; Department of Pediatric Hematology-Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Lopez-Yurda M; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Biometrics, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Janssen JM; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van den Heuvel-Eibrink MM; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; Laille EJ; Cellectis, New York, NY, USA.; Bristol Myers Squibb/Celgene, Summit, NJ, USA.; van Tinteren H; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Zwaan CM; Department of Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.; European Consortium for Innovative Therapies for Children with Cancer (ITCC), Villejuif, France.
Publisher: Springer International Country of Publication: Switzerland NLM ID: 100883685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2019 (Electronic) Linking ISSN: 11745878 NLM ISO Abbreviation: Paediatr Drugs Subsets: MEDLINE
Academic Journal
Schwartz ER; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; Rensen N; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Steur LMH; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; Gemke R; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; van Eijkelenburg NKA; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; van der Sluis IM; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus MC Sophia Children Hospital, Rotterdam, The Netherlands.; Dors N; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Radboudumc, Nijmegen, The Netherlands.; van den Bos C; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Tissing WJE; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, University Medical Centre Groningen, Groningen, The Netherlands.; Grootenhuis MA; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Kaspers GJL; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands.; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Van Litsenburg RRL; Department of Pediatric Oncology, Emma Childrens' Hospital UMC, Amsterdam, The Netherlands R.R.L.vanLitsenburg@prinsesmaximacentrum.nl.; Department of Hematology-oncology, Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
Academic Journal
Gelineau NU; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; van Barneveld A; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Samim A; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Van Zogchel L; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Lak N; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Tas ML; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Matser Y; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Mavinkurve-Groothuis AMC; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; van Grotel M; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Zsiros J; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Knops RRG; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; van Ewijk R; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Langenberg KPS; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Krijger R; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands.; Hiemcke-Jiwa LS; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, Netherlands.; Van Paemel R; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University, Ghent, Belgium.; Research Institute, Ghent University, Ghent, East Flanders, Belgium.; Cornelli L; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; VIB-UGent Center for Medical Biotechnology, Gent, Belgium.; De Preter K; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Research Institute, Ghent University, Ghent, East Flanders, Belgium.; VIB-UGent Center for Medical Biotechnology, Gent, Belgium.; De Wilde B; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, Ghent University, Ghent, Belgium.; Research Institute, Ghent University, Ghent, East Flanders, Belgium.; Van Der Schoot E; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.; Tytgat G; Princess Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, Netherlands.
Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
검색 결과 제한하기
제한된 항목
[Author] van Eijkelenburg NKA
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어